Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

FDA Approves Two Teva Asthma Inhalers

Teva Pharmaceutical Industries Ltd. announced FDA approval of two products for adolescent and adult patients with asthma: AirDuo RespiClick and ArmonAir RespiClick.

Read More »

Incyte and Calithera Biosciences Announce Global Collaboration to Develop and Commercialize CB-1158, a First-in-class, Small Molecule Arginase Inhibitor

Incyte Corporation and Calithera Biosciences Inc. announced that the companies have entered into a global collaboration and license agreement for the research, development and commercialization of Calithera’s first-in-class, small molecule arginase inhibitor CB-1158 in hematology and oncology.

Read More »

Merck Reveals Recent U.S. Drug Price Increases

As drug pricing continues to be a concern for the public and the new presidential administration, Merck pulled back the curtain on its U.S. pricing practices.

Read More »

How Trump’s Immigration Ban is Already Hurting Science

Billed as a measure to bolster national security, President Donald Trump’s executive order blocking travel, immigrants and refugees from seven majority-Muslim countries is having ripple effects impacting the science and biotech communities and could be the start of a brain drain in the U.S.

Read More »

Danish drugmaker Novo Nordisk bets $145 million on post-Brexit UK science

Novo Nordisk – the world’s top maker of diabetes drugs – is investing 115 million pounds ($145 million) in a new research center in Britain, undeterred by Brexit.

Read More »

Summarized Ways to Publishing a Proposal

Custom- Economical and Written Dissertations on Any Matter of the Planet! Commonly inexpensive dissertation-writing providers give pupils with low quality plagiarized function which leaves a poor influence on the scores. Dissertation. While the title implies, provides probably the most affordable dissertation help to you. We never bargain on quality although although you can expect affordable […]

Read More »

Europe faces steep price increases for some old cancer drugs

European prices for some off-patent cancer drugs have risen by more than 100 percent in the past five years, with two cases of hikes exceeding 1,000 percent, according to data presented at a medical conference.

Read More »

Facebook Chief, Chan Charity Buys Artificial Intelligence Startup to Battle Disease

The Chan Zuckerberg Initiative – founded by Priscilla Chan, a physician, and her husband, Facebook chief executive officer Mark Zuckerberg – acquired Torontobased artificial intelligence company Meta.

Read More »

Amgen Receives Positive CHMP Opinion For ABP 501 (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases

Amgen announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing Authorization of ABP 501 (biosimilar adalimumab), recommending approval for all available indications.

Read More »

Pfizer Receives Positive CHMP Opinion in Europe for XELJANZ (tofacitinib citrate) for the Treatment of Moderate to Severe Active Rheumatoid Arthritis

Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion recommending XELJANZ (tofacitinib citrate) 5 mg twice daily for the treatment of patients with moderate to severe active rheumatoid arthritis.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

December 2018 Focus: Healthcare Agency Roundtable, Mobile Marketing, and more!


Ad Right Bottom